L-Dopa-induced desensitization depends on 5-hydroxytryptamine imbalance in hemiparkinsonian rats

NeuroReport

Volumn 20, Issue 3, 2009, Pages 313-318

  Kääriäinen, Tiina M ^a   García Horsman, Juan Arturo ^b   Piltonen, Marjo ^b   Männistö, Pekka T ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

5 hydroxytryptamine; 6 hydroxydopamine; Dopamine; L dopa; Parkinson's disease; Rotational behavior

Indexed keywords

CARBIDOPA PLUS LEVODOPA; DOPAMINE; FENCLONINE; LEVODOPA; OXIDOPAMINE; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DESENSITIZATION; DOPAMINERGIC SYSTEM; DRUG ADMINISTRATION ROUTE; DRUG INFUSION; ENZYME INHIBITION; INTRASTRIATAL DRUG ADMINISTRATION; MALE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; ROTATION; SINGLE DRUG DOSE;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CORPUS STRIATUM; DOPAMINE AGENTS; DRUG INTERACTIONS; DYSKINESIA, DRUG-INDUCED; LEVODOPA; MALE; MOTOR ACTIVITY; MOVEMENT DISORDERS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; ROTATION; SEROTONIN; SYMPATHOLYTICS; TRYPTOPHAN HYDROXYLASE;

EID: 62149101139     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328321e704     Document Type: Article

References (25)

1. Brotchie JM. Nondopaminergic mechanisms in levodopa-induced dyskinesia. Mov Disord 2005; 20:919-931.
2. Kirik D, Rosenblad C, Björklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 1998; 152:259-277.
3. Kumar R, Agarwal AK, Seth PK. Free radical-generated neurotoxicity of 6-hydroxydopamine. J Neurochem 1995; 64:1703-1707.
4. Jacobs BL, Simon SM, Ruimy DD, Trulson ME A quantitative rotational model for studying serotonergic function in the rat. Brain Res 1977; 124:271-281.
5. Giambalvo CT, Snodgrass SR, Uretsky NJ. Effects of serotonin neurotoxins on rotational behavior in the rat. Ann N Y Acad Sci 1978; 305:524-531.
6. Scholtissen B, Deumens R, Leentjens AF, Schmitz C, Blokland A, Steinbusch HW, et al. Functional investigations into the role of dopamine and serotonin in partial bilateral striatal 6-hydroxydopamine lesioned rats. Pharmacol Biochem Behav 2006; 83:175-185.
7. Maeda T, Nagata K, Yoshida Y, Kannari K. Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA Brain Res 2005; 1046:230-233.
8. Katzenschlager R, Lees AJ. Treatment of Parkinson's disease: levodopa as the first choice. J Neurol 2002; 249 (Suppl 2):19-24.
9. Tanaka H, Kannari K, Maeda T, Tomiyama M, Suda T, Matsunaga M. Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. Neuroreport 1999; 10:631-634.
10. Carta M, Carlsson T, Kirik D, Björklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain 2007; 130:1819-1833.
11. Kääriäinen TM, Garcia-Horsman JA, Piltonen M, Huotari M, Männistö PT. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions. Basic Clin Pharmacol Toxicol 2008; 102:300-307.
12. Huotari M, Kukkonen K, Liikka N, Potasev T, Raasmaja A, Männistö PT. Effects of histamine H(3)-ligands on the levodopa-induced turning behavior of hemiparkinsonian rats. Parkinsonism Relat Disord 2000; 6:159-164.
13. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Academic Press: New York; 1986.
14. Airavaara M, Mijatovic J, Vihavainen T, Piepponen TP, Saarma M, Ahtee L. In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered. Synapse 2006; 59:321-329.
15. Green JP. Histamine and serotonin. In: Siegel GJ, Agranoff B, Albers RW, Molinoff P, editors. Basic neurochemistry: molecular, cellular and medical aspects. New York: Raven Press Ltd; 1989. pp. 253-269.
16. Reches A, Wagner HR, Jackson-Lewis V, Yablonskaya-Alter E, Fahn S. Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum. Neurology 1984; 34:1208-1212.
17. Kostrzewa RM. Dopamine receptor supersensitivity. Neurosci Biobehav Rev 1995; 19:1-17.
18. Milson JA Pycock CJ. Effects of drugs acting on cerebral 5-hydroxytryptamine mechanisms on dopamine-dependent turning behaviour in mice. Br J Pharmacol 1976; 56:77-85.
19. Lavoie B, Parent A. Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. J Comp Neurol 1990; 299:1-16.
20. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev 1992; 72:165-229.
21. Carta M, Lindgren HS, Lundblad M, Stancampiano R, Fadda F, Cenci MA. Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats. J Neurochem 2006; 96:1718-1727.
22. Karstaedt PJ, Kerasidis H, Pincus JH, Meloni R, Graham J, Gale K. Unilateral destruction of dopamine pathways increases ipsilateral striatal serotonin turnover in rats. Exp Neurol 1994; 126:25-30.
23. Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, et al. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain 2008; 131:120-131.
24. Kuhn DM, Arthur R Jr. Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons. J Neurosci 1998; 18:7111-7117.
25. Kuhn DM, Arthur RE Jr. L-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein. Brain Res Mol Brain Res 1999; 73:78-84.